Impact of the CFTR-Potentiator Ivacaftor on Airway Microbiota in Cystic Fibrosis Patients Carrying A G551D MutationCédric Bernarde, Geneviève Héry-Arnaud, Marlène Keravec et al.|PLoS ONE|2015Cited by 84
Antimicrobial Resistance in Enterobacterales Recovered from Urinary Tract Infections in FranceÉric Farfour, Laurent Dortet, Thomas Guillard et al.|Pathogens|2022Cited by 34
Insights into the respiratory tract microbiota of patients with cystic fibrosis during early Pseudomonas aeruginosa colonizationMarlène Keravec, Geneviève Héry-Arnaud, Jérôme Mounier et al.|SpringerPlus|2015Cited by 31
<i>Porphyromonas</i> , a potential predictive biomarker of <i>Pseudomonas aeruginosa</i> pulmonary infection in cystic fibrosisMarlène Keravec, Geneviève Héry-Arnaud, Jérôme Mounier et al.|BMJ Open Respiratory Research|2019Cited by 21
Use of denaturing high-performance liquid chromatography (DHPLC) to characterize the bacterial and fungal airway microbiota of cystic fibrosis patientsJérôme Mounier, Geneviève Héry-Arnaud, Audrey Gouëllo et al.|The Journal of Microbiology|2014Cited by 15